Earlier detection of SARS-CoV-2 infection by blood RNA signature microfluidics assay

Clin Transl Discov. 2022 Sep;2(3):e47. doi: 10.1002/ctd2.47. Epub 2022 Jul 10.

Authors

Antonio Cappuccio¹, Jennifer Geis², Yongchao Ge¹, Venugopalan D Nair¹, Naveen Ramalingam², Weiguang Mao³, Maria Chikina³, Andrew G Letizia⁴, Stuart C Sealfon¹

Affiliations

¹ Department of Neurology Icahn School of Medicine at Mount Sinai New York New York USA.
² Fluidigm Corporation San Francisco California USA.
³ Department of Computational and Systems Biology School of Medicine University of Pittsburgh Pittsburgh Pennsylvania USA.
⁴ Naval Medical Research Center Silver Spring Maryland USA.

PMID: 35942160
PMCID: PMC9349572
DOI: 10.1002/ctd2.47

No abstract available

Keywords: COVID‐19; host response assay; infection diagnosis.